FHL2 Antibody (AT21D11) [DyLight 550]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-61162R
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunocytochemistry/ Immunofluorescence, Western Blot
Label
DyLight 550 (Excitation = 562 nm, Emission = 576 nm)
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # AT21D11
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human FHL2 (1-279aa) purified from E. coli.
Reactivity Notes
0
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for FHL2 Antibody (AT21D11) [DyLight 550]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: FHL2
Long Name
Four and a Half LIM Domains Protein 2
Alternate Names
AAG11, DRAL, SLIM3
Gene Symbol
FHL2
Additional FHL2 Products
Product Documents for FHL2 Antibody (AT21D11) [DyLight 550]
Product Specific Notices for FHL2 Antibody (AT21D11) [DyLight 550]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...